Submission Details
| 510(k) Number | K930845 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 18, 1993 |
| Decision Date | April 20, 1993 |
| Days to Decision | 61 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
K930845 is an FDA 510(k) clearance for the ROCHE ABUSCREEN ONTRAK FOR METHADONE, a Hemagglutination Inhibition, Methadone (Class II — Special Controls, product code DIW), submitted by Roche Diagnostic Systems, Inc. (Branchburg, US). The FDA issued a Cleared decision on April 20, 1993, 61 days after receiving the submission on February 18, 1993. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3620.
| 510(k) Number | K930845 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 18, 1993 |
| Decision Date | April 20, 1993 |
| Days to Decision | 61 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
| Product Code | DIW — Hemagglutination Inhibition, Methadone |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3620 |